P01.060 PriCoTTF: a phase I/II trial of Tumor Treating Fields prior and concomitant to radiotherapy in newly diagnosed glioblastoma

Por Glas, M, Scheffler, B, Lazaridis, L, Herrlinger, U, Pierscianek, D, Sure, U, Pröscholdt, M, Hau, P, Hense, J, Kleinschnitz, C, Grosu, A, Stuschke, M, Kebir, S
Publicado no Neuro Oncol (2018)

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic...

Por Lee, Choong-kun, Jung, Minkyu, Choi, Hye Jin, Kim, Hye Ryun, Kim, Hyo Song, Roh, Mi Ryung, Ahn, Joong Bae, Chung, Hyun Cheol, Heo, Su Jin, Rha, Sun Young, Shin, Sang Joon
Publicado no Cancer Res Treat (2015)

A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed...

Por Lester, Jason F, Casbard, Angela C, Al-Taei, Saly, Harrop, Richard, Katona, Lajos, Attanoos, Richard L, Tabi, Zsuzsanna, Griffiths, Gareth O
Publicado no Oncoimmunology (2018)

Randomized, controlled, dose escalation trial of a protease-activated receptor-1 agonist in acute ischemic stroke: Final Results of the RHAPSODY trial.: A multi-center, Phase 2 trial using a continual...

Por Lyden, Patrick, Pryor, Kent E., Coffey, Christopher S., Cudkowicz, Merit, Conwit, Robin, Jadhav, Ashutosh, Sawyer, Robert N., Claassen, Jan, Adeoye, Opeolu, Song, Shlee, Hannon, Peter, Rost, Natalia S., Hinduja, Archana, Torbey, Michel, Lee, Jin-Moo, Benesch, Curtis, Rippee, Michael, Rymer, Marilyn, Froehler, Michael T., Haley, E. Clarke, Johnson, Mark, Yankey, Jon, Magee, Kim, Qidwai, Julie, Levy, Howard, Haacke, E. Mark, Fawaz, Miller, Davis, Thomas P., Toga, Arthur W., Griffin, John H., Zlokovic, Berislav V.
Publicado no Ann Neurol (2019)

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced...

Por Oh, Sung Yong, Kim, Won Seog, Kim, Jin Seok, Kim, Seok Jin, Yoon, Dok Hyun, Yang, Deok-Hwan, Lee, Won Sik, Kim, Hyo Jung, Yhim, Ho-Young, Jeong, Seong Hyun, Won, Jong Ho, Lee, Suee, Kong, Jee Hyun, Lim, Sung-Nam, Ji, Jun Ho, Kwon, Kyung A., Lee, Gyeong-Won, Lee, Jae Hoon, Lee, Ho Sup, Shin, Ho-Jin, Suh, Cheolwon
Publicado no Cancer Commun (Lond) (2019)

A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients...

Por O’Brien, M E R, Saini, A, Smith, I E, Webb, A, Gregory, K, Mendes, R, Ryan, C, Priest, K, Bromelow, K V, Palmer, R D, Tuckwell, N, Kennard, D A, Souberbielle, B E
Publicado em 2000

A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination...

Por Engel-Riedel, Walburga, Lowe, Jamie, Mattson, Paulette, Richard Trout, J., Huhn, Richard D., Gargano, Michele, Patchen, Myra L., Walsh, Richard, Trinh, My My, Dupuis, Mariève, Schneller, Folker
Publicado no J Immunother Cancer (2018)

Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

Por Niess, Hanno, von Einem, Jobst C, Thomas, Michael N, Michl, Marlies, Angele, Martin K, Huss, Ralf, Günther, Christine, Nelson, Peter J, Bruns, Christiane J, Heinemann, Volker
Publicado no BMC Cancer (2015)

AB040. P-08. FOENIX-CCA2: a phase 2 study of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements

Por Furuse, Junji, Goyal, Lipika, Bahleda, Rastsilav, Valle, Juan, Moehler, Markus, Oh, Do-Youn, Chang, Heung-Moon, Kelley, Robin Kate, Javle, Milind, Borad, Mitesh, Chen, Li-Tzong, Uboha, Nataliya, Klümpen, Heinz-Josef, O’Dwyer, Peter J., Li, Daneng, Morizane, Chigusa, Huang, Jerry, Bridgewater, John A.
Publicado no Hepatobiliary Surg Nutr (2019)

A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese...

Por Hou, Jian, Du, Xin, Jin, Jie, Cai, Zhen, Chen, Fangping, Zhou, Dao-bin, Yu, Li, Ke, Xiaoyan, Li, Xiao, Wu, Depei, Meng, Fanyi, Ai, Huisheng, Zhang, Jingshan, Wortman-Vayn, Honeylet, Chen, Nianhang, Mei, Jay, Wang, Jianmin
Publicado em 2013

Safety and Efficacy of HIV Hyperimmune Globulin (HIVIGLOB) for Prevention of Mother-to-Child HIV...

Por Onyango-Makumbi, Carolyne, Omer, Saad B., Mubiru, Michael, Moulton, Lawrence H., Nakabiito, Clemensia, Musoke, Philippa, Mmiro, Francis, Zwerski, Sheryl, Wigzell, Hans, Falksveden, Lars, Wahren, Britta, Antelman, Gretchen, Fowler, Mary Glenn, Guay, Laura, Jackson, J. Brooks
Publicado em 2011

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate...

Por Omollo, Raymond, Alexander, Neal, Edwards, Tansy, Khalil, Eltahir AG, Younis, Brima M, Abuzaid, Abuzaid A, Wasunna, Monique, Njoroge, Njenga, Kinoti, Dedan, Kirigi, George, Dorlo, Thomas PC, Ellis, Sally, Balasegaram, Manica, Musa, Ahmed M
Publicado em 2011

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced...

Por Jones, R L, Demetri, G D, Schuetze, S M, Milhem, M, Elias, A, Van Tine, B A, Hamm, J, McCarthy, S, Wang, G, Parekh, T, Knoblauch, R, Hensley, M L, Maki, R G, Patel, S, von Mehren, M
Publicado no Ann Oncol (2018)

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

Por Ettrich, Thomas J., Perkhofer, Lukas, von Wichert, Goetz, Gress, Thomas M., Michl, Patrick, Hebart, Holger F., Büchner-Steudel, Petra, Geissler, Michael, Muche, Rainer, Danner, Bettina, Kächele, Volker, Berger, Andreas W., Güthle, Melanie, Seufferlein, Thomas
Publicado no BMC Cancer (2016)

Nearly Pain-Free Self-administration of Subcutaneous Methotrexate With an Autoinjector: Results of a Phase 2 Clinical Trial in Patients With Rheumatoid Arthritis Who Have Functional Limitations

Por Freundlich, Bruce, Kivitz, Alan, Jaffe, Jonathan S.
Publicado em 2014

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety...

Por Blackhall, Fiona, Ross Camidge, D, Shaw, Alice T, Soria, Jean-Charles, Solomon, Benjamin J, Mok, Tony, Hirsh, Vera, Jänne, Pasi A, Shi, Yuankai, Yang, Pan-Chyr, Pas, Tommaso De, Hida, Toyoaki, Carpeño, Javier De Castro, Lanzalone, Silvana, Polli, Anna, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Kim, Dong-Wan
Publicado no ESMO Open (2017)

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability...

Por Steg, Ph. Gabriel, Mehta, Shamir R., Jukema, J. Wouter, Lip, Gregory Y.H., Gibson, C. Michael, Kovar, Frantisek, Kala, Petr, Garcia-Hernandez, Alberto, Renfurm, Ronny W., Granger, Christopher B.
Publicado em 2011

1955. A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy...

Por Kim, Jason, Nakwa, Firdose Lambey, Motta, Fábio De Araujo, Lozada, Perla Salcedo, Alabaz, Derya, Liu, Hong, Bloise, Keisha, Dorr, Mary Beth, Gaffney, Leah J Anderson, Kartsonis, Nicholas
Publicado no Open Forum Infect Dis (2018)

Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Por Cho, Jang Ho, Lim, Sung Hee, An, Ho Jung, Kim, Ki Hwan, Park, Keon Uk, Kang, Eun Joo, Choi, Yoon Hee, Ahn, Mi Sun, Lee, Myung Hee, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado no J Clin Oncol (2020)

Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)()

Por Loibl, Sibylle, de la Pena, Lorena, Nekljudova, Valentina, Zardavas, Dimitrios, Michiels, Stefan, Denkert, Carsten, Rezai, Mahdi, Bermejo, Begoña, Untch, Michael, Lee, Soo Chin, Turri, Sabine, Urban, Patrick, Kümmel, Sherko, Steger, Guenther, Gombos, Andrea, Lux, Michael, Piccart, Martine J., Von Minckwitz, Gunter, Baselga, José, Loi, Sherene
Publicado no Eur J Cancer (2017)